218 related articles for article (PubMed ID: 20400503)
1. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.
Narala VR; Adapala RK; Suresh MV; Brock TG; Peters-Golden M; Reddy RC
J Biol Chem; 2010 Jul; 285(29):22067-74. PubMed ID: 20400503
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor alpha activator, Wy14,643, is anti-inflammatory in vivo.
Colville-Nash P; Willis D; Papworth J; Freemantle C; Lam C; Andrews G; Willoughby D
Inflammopharmacology; 2005; 12(5-6):493-504. PubMed ID: 16259717
[TBL] [Abstract][Full Text] [Related]
3. Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4).
Devchand PR; Hihi AK; Perroud M; Schleuning WD; Spiegelman BM; Wahli W
J Biol Chem; 1999 Aug; 274(33):23341-8. PubMed ID: 10438511
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats.
Kurtz M; Capobianco E; Careaga V; Martinez N; Mazzucco MB; Maier M; Jawerbaum A
J Endocrinol; 2014 Mar; 220(3):345-59. PubMed ID: 24389592
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling of the peroxisome proliferator-activated receptor alpha (PPAR alpha) from human, rat and mouse, based on homology with the human PPAR gamma crystal structure.
Lewis DF; Jacobs MN; Dickins M; Lake BG
Toxicol In Vitro; 2002 Jun; 16(3):275-80. PubMed ID: 12020601
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats.
Martínez N; Capobianco E; White V; Pustovrh MC; Higa R; Jawerbaum A
Reproduction; 2008 Jul; 136(1):95-103. PubMed ID: 18417641
[TBL] [Abstract][Full Text] [Related]
7. Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.
Talahalli R; Zarini S; Sheibani N; Murphy RC; Gubitosi-Klug RA
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1699-708. PubMed ID: 19834040
[TBL] [Abstract][Full Text] [Related]
8. Atypical lambda/iota PKC conveys 5-lipoxygenase/leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-kappa B activation in response to tumor necrosis factor-alpha and interleukin-1beta.
Anthonsen MW; Andersen S; Solhaug A; Johansen B
J Biol Chem; 2001 Sep; 276(38):35344-51. PubMed ID: 11445585
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands.
Hostetler HA; Petrescu AD; Kier AB; Schroeder F
J Biol Chem; 2005 May; 280(19):18667-82. PubMed ID: 15774422
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade.
Woo CH; Eom YW; Yoo MH; You HJ; Han HJ; Song WK; Yoo YJ; Chun JS; Kim JH
J Biol Chem; 2000 Oct; 275(41):32357-62. PubMed ID: 10934206
[TBL] [Abstract][Full Text] [Related]
11. Targeting leukotriene B4 in inflammation.
Di Gennaro A; Haeggström JZ
Expert Opin Ther Targets; 2014 Jan; 18(1):79-93. PubMed ID: 24090264
[TBL] [Abstract][Full Text] [Related]
12. Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis.
Chen M; Lam BK; Luster AD; Zarini S; Murphy RC; Bair AM; Soberman RJ; Lee DM
J Immunol; 2010 Nov; 185(9):5503-11. PubMed ID: 20876351
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli.
Costa MF; de Souza-Martins R; de Souza MC; Benjamim CF; Piva B; Diaz BL; Peters-Golden M; Henriques Md; Canetti C; Penido C
J Leukoc Biol; 2010 Feb; 87(2):323-32. PubMed ID: 19880577
[TBL] [Abstract][Full Text] [Related]
14. Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation.
Kannan S
Med Hypotheses; 2002 Sep; 59(3):261-5. PubMed ID: 12208150
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
Schoonjans K; Martin G; Staels B; Auwerx J
Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
[TBL] [Abstract][Full Text] [Related]
16. 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity.
Gagnon KJ; Lefort N; Poirier SJ; Barnett DA; Surette ME
Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():38-44. PubMed ID: 30392579
[TBL] [Abstract][Full Text] [Related]
17. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
Gani OA
Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.
Talvani A; Machado FS; Santana GC; Klein A; Barcelos L; Silva JS; Teixeira MM
Infect Immun; 2002 Aug; 70(8):4247-53. PubMed ID: 12117933
[TBL] [Abstract][Full Text] [Related]
19. PPARα agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats.
Martínez N; Kurtz M; Capobianco E; Higa R; White V; Jawerbaum A
J Mol Endocrinol; 2011 Aug; 47(1):1-12. PubMed ID: 21502283
[TBL] [Abstract][Full Text] [Related]
20. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis.
Murray J; Ward C; O'Flaherty JT; Dransfield I; Haslett C; Chilvers ER; Rossi AG
Br J Pharmacol; 2003 May; 139(2):388-98. PubMed ID: 12770944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
